Dr. Andrew Huberman — Peptides, Performance, and Protocols
A two-hour Ferriss and Huberman conversation. About 40 minutes of it is an opinionated tour of peptides: GLP-1 drugs, growth hormone secretagogues, BPC-157, pinealon, and the gray market.
With Tim Ferriss, Andrew Huberman
Key moments
Tap a moment to play the video from there.
- 4:56Training with Dorian YatesHuberman describes training with Yates and explains why he keeps a low volume, high intensity split. This is the non-peptide material that opens the episode.
- 56:24Peptides defined and sortedFerriss asks what peptides are. Huberman calls them short chains of amino acids and starts grouping them into categories.
- 58:19GLP-1 drugs and retatrutideHuberman discusses weight loss peptides, muscle loss, appetite effects, nausea, micro dosing, and gray market retatrutide.
- 1:00:52Growth hormone secretagoguesHuberman describes the class and his own brief trial: more deep sleep, less REM, and a PSA rise that reversed. He says prescribed growth hormone seems preferable to these peptides.
- 1:03:25BPC-157 and its evidenceHuberman gives his experience with BPC-157, says the human evidence is absent, and covers the TB-500 combination.
- 1:05:30Compounding pharmacies versus gray marketHuberman says compounded products are likely cleaner than research-use-only sellers and names pharmacies he considers better known.
- 1:10:37Epitalon, pinealon, and REM sleepHuberman covers epitalon and pinealon, his own REM sleep and jet lag experiments, and non-drug ways to raise REM.
- 1:18:04Women as the peptide marketHuberman argues the main buyers are women, naming low dose GLP-1 use and GHK copper, and discusses melanotan.
- 1:28:55Why no reported side effects misleadsFerriss and Huberman discuss why a lack of reported harms is weak evidence, and cover injection hygiene and cautious use.
What the video says
This is a wide-ranging conversation recorded in Malibu between host Tim Ferriss and Andrew Huberman. Most of it is not about peptides. It covers Dorian Yates style resistance training and Huberman's weekly split, his experiences with MDMA and psilocybin, a one day brain stimulation protocol, cortisol, AI and wearables, and his upcoming book Protocols. The peptide section runs from roughly 56:24 to 96:00, and it is spoken opinion and personal anecdote, not a review of trial data.
Huberman sorts peptides into categories. He starts with GLP-1 type weight loss drugs, calling retatrutide the most effective of the group and saying it seems to spare some muscle. He adds that gray market versions are already being sold and that some people take micro doses to reduce nausea. Next are growth hormone secretagogues. He says they typically produce a three to eightfold rise in growth hormone and IGF-1. He tried one briefly and reports more slow wave sleep, less REM sleep, and a PSA rise that reversed when he stopped. He says that if someone can get a prescription, low dose pharmaceutical growth hormone seems a more obvious choice than unknown secretagogue peptides.
On BPC-157, Huberman says he felt recovery after strains was faster but cannot separate local from systemic effects. He describes the preclinical literature as impressive and says there is no published human trial. He recommends compounding pharmacies over research-use-only sellers and questions taking it ongoing without an injury. Ferriss says he used a BPC and TB-500 combination after elbow surgery and cannot tell whether it helped. Huberman also describes using pinealon occasionally for more REM sleep, mentions epitalon only briefly with vague mechanisms, and says women, not gym users, are the largest peptide market, citing GHK copper and low dose GLP-1 use.
Later, both men urge caution. Ferriss argues that a lack of reported adverse events from gray market products says little, because no reporting system exists. Huberman says he has become conservative, favors tools with long safety records, and stresses injection hygiene.
On each compound
Retatrutide58:19
Huberman says retatrutide acts on the GLP, GIP and glucagon systems, produces the most weight loss of the GLP drugs, and seems to spare some muscle. He says it is not formally released but is already sold on the gray market.
See how your DNA reads RetatrutideTirzepatide1:16:41
Huberman says he has never used a GLP drug but is curious about the low dose tirzepatide use people discuss for cognitive and neuroprotective effects. He also mentions interesting data on eye pressure. He and Ferriss note the mechanism would need to be separate from the metabolic effects.
See how your DNA reads TirzepatideBPC-1571:03:25
Huberman says he feels recovery after a strain is faster with it but cannot run a control. He says preclinical results are impressive, no human trial exists, and he would not take it without an injury. He later says it can promote blood vessel growth, which he flags as a concern for tumors.
See how your DNA reads BPC-157TB-5001:06:00
Huberman mentions BPC-157 combined with TB-500, called the Wolverine stack, and says he has never tried TB-500. Ferriss says he took the combination after elbow surgery and cannot tell whether it helped.
See how your DNA reads TB-500Sermorelin1:01:22
Huberman says he briefly tried a growth hormone secretagogue that the captions render as Smurellin, probably sermorelin. He reports more slow wave sleep, less REM sleep, a PSA rise that normalized after stopping, and no clear fat loss or strength gain.
See how your DNA reads SermorelinIpamorelin1:00:52
Huberman lists growth hormone secretagogues, with a caption-garbled name that may be ipamorelin. He says they work by prompting the brain to stimulate nighttime growth hormone release, with a three to eightfold rise, and that he does not find the effects worth it.
See how your DNA reads IpamorelinTesamorelin1:00:52
Huberman lists a caption-garbled name that may be tesamorelin among the growth hormone secretagogues. He says none of them seem worth it to him personally because the effects are modest.
See how your DNA reads TesamorelinCJC-12951:01:53
Huberman says CJC and its variants can cause some insulin resistance but may raise growth hormone somewhat more. He says he does not know and does not find these worth it.
See how your DNA reads CJC-1295Epithalon1:10:37
Huberman says epitalon is thought to preserve histone and DNA structure, calls the idea vague, and mentions preclinical data on visual repair. He says he tried a capsule for jet lag with morning sunlight and could not tell whether it did anything.
See how your DNA reads EpithalonGHK-Cu1:18:45
Huberman says many women use GHK copper in cream or injectable form. He cites studies suggesting that with red light or limited sun it might reduce wrinkles.
See how your DNA reads GHK-CuMelanotan II1:22:21
Huberman says melanotan tans people, can overdo it, and can cause priapism and greatly increased libido. He has not tried it.
See how your DNA reads Melanotan II“There's not a single published human trial.”
“absence of evidence does not equal evidence of absence”
What this video doesn’t settle
- Almost everything about dose, effect and sleep change comes from Huberman's and Ferriss's own experience, with no control group or blinding.
- Huberman says there is no published human trial of BPC-157 and that he does not expect a proper one to be run, so its effects in people stay unmeasured here.
- The video does not establish whether gray market or compounded peptides are pure, since the discussion of sourcing rests on opinion about which sellers are trustworthy.
Questions this video answers
What does Huberman say about BPC-157?
He says he feels recovery from strains is faster with it, but he cannot isolate the effect because it acts systemically. He describes the preclinical literature as impressive and notes there is not a single published human trial. He says he would not take it ongoing without an injury.
Does Huberman recommend growth hormone secretagogue peptides?
No. He says the three to eightfold rise in growth hormone does not translate into robust fat loss or strength in his view. He reports a PSA rise during his own brief trial that normalized after stopping. He says prescribed low dose growth hormone seems a more obvious choice if someone can get a script.
What does Huberman say about buying peptides online?
He says research-use-only products are sold legally but carry a concern about contamination or not getting what the label says. He says compounding pharmacies with a prescription are likely cleaner, though they vary in stringency. He says he has no relationship with the pharmacies he names.
Why do Ferriss and Huberman say a lack of reported side effects is not reassuring?
Huberman notes he knows of no reported adverse event tied to non-FDA-approved peptides. Ferriss replies that this does not equal safety, because gray market use has no real reporting mechanism. He compares it to a new motorcycle with no recorded deaths because few people have ridden it.
What does Huberman say about pinealon?
He says he uses it occasionally by subcutaneous injection and reports roughly three hours of REM sleep that night without disrupting deep sleep. He says the effect seemed to carry over to later nights. He calls the evidence thin and suggests trying light, caffeine and supplement changes first.
Video by Tim Ferriss on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
